UPDATE: Glaxo "particularly pleased" with daprodustat Phase 3 results Read More
IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors Read More
TOP NEWS: Glaxo eyes developer to turn UK asset into life sciences hub Read More
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties Read More
BROKER RATINGS: Jefferies cuts British Land and Landsec to Hold Read More
Moody's raises GSK outlook to stable as tips debt cut amid spin-off Read More
UPDATE: Glaxo joins Alector on brain treatment trials; backs leader Read More
LONDON MARKET MIDDAY: Stocks edge higher ahead of US jobs report Read More
TOP NEWS: GSK backs Walmsley to lead pharma after Elliott criticism Read More
Evotec acquires Italian R&D site from GlaxoSmithKline Read More
LONDON MARKET CLOSE: Oil and retailers propel FTSE into new quarter Read More
UK dividends calendar - next 7 days Read More
TOP NEWS: Elliott calls for "right leadership" at Glaxo to lift value Read More
BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart Read More
LONDON MARKET MIDDAY: Stocks slide; UK roadmap announcement ahead Read More
LONDON MARKET OPEN: Burberry sinks as CEO Gobbetti heads home Read More
PRESS: GSK hires Goldman and Citi for spinoff of Consumer Healthcare Read More
BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold Read More
TOP NEWS: AstraZeneca prostate cancer drug Lynparza backed in China Read More
LONDON MARKET CLOSE: Stocks edge lower as PMI does little to impress Read More
